nasal
- Product NDC
- 11822-6319
- 11-digit product format
- 118226319
- Labeler code
- 11822
- Product ID
- 11822-6319_5c809981-45d4-4ab5-a803-34da80473901
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Oxymetazoline Hydrochloride
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Labeler
- Rite Aid Corporation
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-12-05
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .05 g/100mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- nasal
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXYMETAZOLINE HYDROCHLORIDE | .05 g/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K89MJ0S5VY |
| Rxcui | 1000990 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11822-6319-1 | nasal | 1 in 1 CARTON | SPRAY, METERED | 1 | | 2 |
| 11822-6319-1 | nasal | 30 mL in 1 BOTTLE, SPRAY | SPRAY, METERED | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11822-6319 | NASAL (OXYMETAZOLINE HYDROCHLORIDE) SPRAY, METERED [RITE AID CORPORATION] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240906_6c949602-e0c8-40ce-8fb3-5147f406fa04.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11822-6319-1 | 11822631901 | 1 BOTTLE, SPRAY in 1 CARTON (11822-6319-1) / 30 mL in 1 BOTTLE, SPRAY | 2018-12-05 | 0000-00-00 | No | No | Current |